aminocaproic acid has been researched along with Leukemia, Myeloid in 1 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CATTAN, A | 1 |
| SCHWARZENBERG, L | 1 |
| SCHNEIDER, M | 1 |
| AMIEL, JL | 1 |
| MATHE, G | 1 |
1 other study available for aminocaproic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
[TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].
Topics: Aminocaproates; Aminocaproic Acid; Anemia; Anemia, Aplastic; Humans; Leukemia; Leukemia, Lymphoid; L | 1963 |